Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company dedicated to investigating potential therapeutics for cancer and inflammatory dermatoses.
Our Contact Form | Mailing Address |
Telephone: +1 (866) 594-5999 |
Provectus Biopharmaceuticals, Inc.
|
Investor Relations | Media Relations |
Provectus Biopharmaceuticals, Inc.
|
Provectus Biopharmaceuticals, Inc. |
Transfer Agent | |
(i.e. stockholder records, transfer, change of address, etc.) |
Today's Open | 0.06 |
Volume | 45,921 |
Day Range | 0.06 - 0.07 |
52 Week Range | 0.01 - 0.07 |
Bid/Ask | 0.06 / 0.07 |
Bid/Ask Size | 17,100 X 53,697 |
Previous Close | 0.06 |
Market Cap | 24.48 million |
Shares Outstanding | 388.58 million |
Dividend/Yield | 0.00 / 0.00% |
EPS (TTM) | -0.02 |
P/E Ratio (TTM) | N/A |